Concepedia

Anusha Shirwaikar Thomas

AS

Statistics

Publications

17

Citations

680

H-Index

14

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Baylor College of Medicine

Second Xiangya Hospital of Central South University

Central South University

Anusha Shirwaikar Thomas is an author at The University of Texas MD Anderson Cancer Center specializing in immunotherapy, immunology, and medicine.

Top concepts

Publications per year

2020–2024

17

Publications

17

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

Taylor M. Halsey, Anusha Shirwaikar Thomas, Tomo Hayase et al. · Science Translational Medicine · 2023 · 118 citations · Full text

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Fangwen Zou, David M. Faleck, Anusha Shirwaikar Thomas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 111 citations · Full text

Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors

Anusha Shirwaikar Thomas, Weijie Ma, Yinghong Wang · New England Journal of Medicine · 2021 · 87 citations · Full text

, , +15

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Fangwen Zou, Xuemei Wang, Isabella C. Glitza Oliva et al. · Journal for ImmunoTherapy of Cancer · 2021 · 67 citations · Full text

Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases

Antonio Pizuorno Machado, Malek Shatila, Cynthia Liu et al. · Journal of Cancer Research and Clinical Oncology · 2023 · 57 citations · Full text

, , +14

1–5 of 17